
Clinical Scientist in microbiology. Interests: AMR; epidemiology of Gram-negatives; diagnostics for resistance detection. Views my own. @theamrdoc@mstdn.science
London, United Kingdom
Joined March 2021
- Tweets1.1K
- Following729
- Followers736
- Likes2K
Come join us in @UKHSA’s Antimicrobial Resistance and Healthcare Associated Infections Reference Unit - the UK’s national reference laboratory for #AntimicrobialResistance
beta.jobs.nhs.uk/candidate/j…
Katie Hopkins retweeted
🆕💫Antimicrobial Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia Isolates /Europe, Asia,Latin America (2018–2023)
1,287 clinical isolates
71 medical centres 🌎
Aztreonam-avibactam most active 99.5%
Bactrim 95.6/96.3% S per CLSI/EUCAST
ijidonline.com/article/S1201…
New from @UKHSA AMRHAI Reference Unit and AMR & HCAI Division colleagues:
A case of penicillin-resistant group B Streptococcus isolated from a patient in the UK academic.oup.com/jac/article…
#AntimicrobialResistance
Katie Hopkins retweeted
The Sanger Prize Competition 2025 - calling for undergraduate students in LMICs
The winner will be offered a 3month internship with travel, living and research expenses are all covered by the award. sanger.ac.uk/about/the-sange… #sangerinstitute
Katie Hopkins retweeted
PUBLISHED: The 2023-24 English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report gov.uk/government/publicatio…
Register to find out more about the findings in the report at the webinar we are hosting on 20th November: antibioticguardian.com/Meeti…
Katie Hopkins retweeted
🆕️🔥Narrative Review @CMIJournal
Aztreonam and Avibactam Combination Therapy for Metallo-β-Lactamase-Producing Gram-Negative Bacteria #MBL #IDXposts
clinicalmicrobiologyandinfec…
Katie Hopkins retweeted
The increasing report of NDM-producing E. coli isolates that are resistant to either aztreonam-avibactam and/or cefiderocol is major source of concern!
Potent in-vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli #idxposts
clinicalmicrobiologyandinfec…
Detection, identification and quantification of #AntimicrobialResistance in river water undertaken by @UKHSA @EnvAgency and @TheQuadram
gov.uk/government/publicatio…
Come join us at the UK’s national reference lab for AMR and HCAIs - permanent AfC8b Clinical Scientist role leading Staph and Strep Service.
Apply here: beta.jobs.nhs.uk/candidate/j…
Katie Hopkins retweeted
We are running a massive online open course on AMR databases starting end of the month. Its completely free, study at your own pace and its ~15 hours overall over the 3 weeks (although you can finish any time in a year). Please spread in your networks! coursesandconferences.wellco…
Katie Hopkins retweeted
Exciting times! A big paper I was involved in has dropped @NatureMicrobiol.
100 cases of phage therapy facilitated by a Belgian consortium showing 77.2% clinical improvement. I will go through the results below put please read 👇
nature.com/articles/s41564-0…
Katie Hopkins retweeted
Join us for an interesting webinar on the challenge of manufacturing and procuring #antibiotics responsibly 🌍
📅5 June, 12-1pm BST
🔗Free registration: page.bsigroup.com/l/73472/20…
@BSI_UK @ShionogiUS
PLEASE SHARE
We're hiring for a permanent HEO role within the AMRHAI Reference Unit!
Details: healthjobsuk.com/job/v633452…
#AntimicrobialResistance
Katie Hopkins retweeted
We are delivering a 6-part Global Antimicrobial Resistance webinar series with speakers from the UK and countries around the world. If you would like to learn more about webinar 6 -
Evaluating an Antimicrobial Stewardship Programme, please click here ow.ly/tJzS50RazYr
Katie Hopkins retweeted
The updated Bacterial Priority Pathogens List features 15 families of antibiotic-resistant bacteria.
To guide the development of new treatments to prevent #AntimicrobialResistance, it sorts them into priorities:
🚨 critical
🔴 high
🟠 medium
More about the list and #AMR: bit.ly/4apqHoQ
WHO publish their 2024 Bacterial Priority Pathogens List:
who.int/news/item/17-05-2024…
Where does your favourite pathogen sit?
#AntimicrobialResistance
Katie Hopkins retweeted
#IDTwitter
I always thought of SUL-DUR as a 🦀 agent only.
I’ve yet to see an NDM E. coli w/ PBP3 mutation, but I’m sure it’s just a matter of time b4 it pops up in Chicago
Good to know that durlobactam may work @OncDPharmd @jpogue1 @ryankshields
doi.org/10.1093/cid/ciae229
Katie Hopkins retweeted
In vitro-in vivo discordance in β-lactams activities against MBL producing Enterobacterales has been described
🔥Deciphering the Efficacy of β-Lactams in the Face of MBL Derived Resistance in Enterobacterales
Supraphysiologic Zinc in Broth is the Culprit🔥 academic.oup.com/ofid/articl…

















